Testing for parasitic infections in people with blood disorders
Part of Blood & lymphatic clinical trials.
This study checks for parasite infections in people with blood conditions like anaemia or blood cancer, comparing them to healthy people. It aims to find out if these infections are more common in patients with these blood disorders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 2 years old.
- You must have either anaemia, a blood cancer (such as leukaemia or lymphoma), or be healthy without these conditions.
- You cannot have taken antiparasitic medicine in the last 4 weeks.
- You cannot have had a blood transfusion in the last 4 weeks.
- You cannot have HIV.
- You must be able to provide a stool sample and a blood sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
This study asks healthy adults to provide blood, bone marrow (if needed), skin, saliva, and stool samples. Scientists use these samples to compare patterns related to myeloid (bone-marrow) blood cancers, which may help future research and tests.
This study looks at blood samples from people with blood cancers to find markers that might predict how well immunotherapy will work. The goal is to help doctors choose the right treatment for each person.
This trial tests a blood test that looks for infection by analyzing tiny bits of DNA from microbes. It may help find infections faster in people with weakened immune systems, such as transplant recipients or those with blood cancers.
This study looks for early signs of disease in healthy adults by checking blood and other samples. It may help find diseases sooner in the future.
This study looks at how the immune system works in people who have—or might have—an increased risk of infections. It also enrolls their healthy blood relatives so researchers can compare immune features; results may help doctors understand who is at higher risk and why.
Hear when a new Haematological Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.